Measles and its virus;La rougeole et son virus

Virologie

Volumn 15, Issue 1, 2011, Pages 6-22

  Freymuth, François ^a   Dina, Julia ^a   Parent Du Chatelet, Isabelle ^b   Mourez, Bénédicte ^a   Waku Kouomou, Diane ^c,d   Vabret, Astrid ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSTITUT DE VEILLE SANITAIRE   (France)

^c CENTRE INTERNATIONAL DE RECHERCHE EN INFECTIOLOGIE   (France)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Genotype D4; Measles; Outbreak

Indexed keywords

IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE; VIRUS RNA;

EPIDEMIC; FRANCE; GENOTYPE; HUMAN; MEASLES; MEASLES VACCINATION; PARAMYXOVIRUS; REVIEW; SALIVA ANALYSIS; VIRUS STRAIN;

PARAMYXOVIRIDAE;

EID: 79952393716     PISSN: 12678694     EISSN: 19506961     Source Type: Journal    
DOI: 10.1684/vir.2011.0380     Document Type: Review

References (85)

1. Furuse Y, Suzuki A, Oshitani H. Origin of measles virus: divergence from rinderpest virus between the 11th and 12th centuries. Virol J 2010; 7: 52.
2. Campbell P. Étude historique de la rougeole. Caen: Thèse Médecine, 1976.
3. th ed. Philadelphia: Lippincott Williams and Wilkins, 2007 (Virology F, ed).
4. Enders JF, Peebles TC. Propagation in tissue cultures of cytopathogenic agents from patients with measles. Proc Soc Exp Biol Med 1954; 86: 277-86.
5. Naniche D, Varior-Krishnan G, Cervoni F, et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67: 6025-32. (Pubitemid 23277513)
6. Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-7. (Pubitemid 30664265)
7. Yanagi Y, Takeda M, Ohno S, Seki F. Measles virus receptors and tropism. Jpn J Infect Dis 2006; 59: 1-5.
8. de Witte L, Abt M, Schneider-Schaulies S, van Kooyk Y, Geijtenbeek TB. Measles virus targets DC-SIGN to enhance dendritic cell infection. J Virol 2006; 80: 3477-86.
9. Hahm B. Hostile communication of measles virus with innate immunity and dendritic cells. In: Griffin DE, Oldstone MBA, editors. Measles. Pathogenesis and control. Berlin: Springer, 2009, p. 271-87.
10. Fontana JM, Bankamp B, Bellini WJ, Rota PA. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 2008; 374: 71-81.
11. Stokes Jr. J, Reilly CM, Buynak EB, Hilleman MR. Immunologic studies of measles. Am J Hyg 1961; 74: 293-303.
12. Bouche FB, Ertl OT, Muller CP. Neutralizing B cell response in measles. Viral Immunol 2002; 15: 451-71.
13. Muller CP, Huiss S, Schneider F. Secondary immune responses in parents of children with recent measles. Lancet 1996; 348: 1379-80. (Pubitemid 26383782)
14. Damien B, Huiss S, Schneider F, Muller CP. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. J Med Virol 1998; 56: 85-90. (Pubitemid 28380435)
15. Klingele M, Hartter HK, Adu F, Ammerlaan W, Ikusika W, Muller CP. Resistance of recent measles virus wild-type isolates to antibody-mediated neutralization by vaccines with antibody. J Med Virol 2000; 62: 91-8.
16. Sheshberadaran H, Norrby E. Characterization of epitopes on the measles virus hemagglutinin. Virology 1986; 152: 58-65. (Pubitemid 16065529)
17. Rota JS, Hummel KB, Rota PA, Bellini WJ. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 1992; 188: 135-42.
18. Rima BK, Earle JA, Baczko K, et al. Sequence divergence of measles virus haemagglutinin during natural evolution and adaptation to cell culture. J Gen Virol 1997; 78(Pt 1): 97-106. (Pubitemid 27067518)
19. Schrag SJ, Rota PA, Bellini WJ. Spontaneous mutation rate of measles virus: direct estimation based on mutations conferring monoclonal antibody resistance. J Virol 1999; 73: 51-4. (Pubitemid 28565345)
20. Santibanez S, Niewiesk S, Heider A, et al. Probing neutralizingantibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?. J Gen Virol 2005; 86: 365-74. (Pubitemid 40227948)
21. Perry RT, Halsey NA. The clinical significance of measles: a review. J Infect Dis 2004; 189(suppl. 1): S4-S16. (Pubitemid 38639562)
22. Johnson RT, Griffin DE, Hirsch RL, et al. Measles encephalomyelitis - clinical and immunologic studies. N Engl J Med 1984; 310: 137-41. (Pubitemid 14224106)
23. Sever JL. Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis. Rev Infect Dis 1983; 5: 467-73.
24. Rima BK, Duprex WP. Molecular mechanisms of measles virus persistence. Virus Res 2005; 111: 132-47. (Pubitemid 40909732)
25. Campbell H, Andrews N, Brown KE, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007; 36: 1334-48. (Pubitemid 350239003)
26. Barkin RM. Measles mortality. Analysis of the primary cause of death. Am J Dis Child 1975; 129: 307-9. (Pubitemid 8001058)
27. Sabella C. Measles: not just a childhood rash. Cleve Clin J Med 2010; 77: 207-13.
28. Atmar RL, Englund JA, Hammill H. Complications of measles during pregnancy. Clin Infect Dis 1992; 14: 217-26.
29. Kaplan LJ, Daum RS, Smaron M, McCarthy CA. Severe measles in immunocompromised patients. JAMA 1992; 267: 1237-41.
30. Parent du Chatelet I, Antona D, Freymuth F, et al. Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010. Euro Surveill 2010; 15: 1-4.
31. Fulginiti VA, Eller JJ, Downie AW, Kempe CH. Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccines. JAMA 1967; 202: 1075-80.
32. Cherry JD. Contemporary infectious exanthems. Clin Infect Dis 1993; 16: 199-205.
33. Lievano FA, Papania MJ, Helfand RF, et al. Lack of evidence of measles virus shedding in people with inapparent measles virus infections. J Infect Dis 2004; 189(suppl. 1): S165-70.
34. Nagai M, Xin JY, Yoshida N, et al. Modified adult measles in outbreaks in Japan, 2007-2008. J Med Virol 2009; 81: 1094-101.
35. Mosquera MM, de Ory F, Gallardo V, et al. Evaluation of diagnostic markers for measles virus infection in the context of an outbreak in Spain. J Clin Microbiol 2005; 43: 5117-21. (Pubitemid 41484014)
36. Helfand RF, Kim DK, Gary Jr. HE, et al. Nonclassic measles infections in an immune population exposed to measles during a college bus trip. J Med Virol 1998; 56: 337-41. (Pubitemid 28516602)
37. Aaby P, Bukh J, Leerhoy J, Lisse IM, Mordhorst CH, Pedersen IR. Vaccinated children get milder measles infection: a community study from Guinea-Bissau. J Infect Dis 1986; 154: 858-63. (Pubitemid 17181613)
38. Monto AS. Interrupting the transmission of respiratory tract infections: theory and practice. Clin Infect Dis 1999; 28: 200-4. (Pubitemid 29241199)
39. Christensen PE, Schmidt H, Bang HO, Andersen V, Jordal B, Jensen O. An epidemic of measles in southern Greenland, 1951; measles in virgin soil. III. Measles and tuberculosis. Acta Med Scand 1953; 144: 450-4.
40. Orenstein WA, Papania MJ, Wharton ME. Measles elimination in the United States. J Infect Dis 2004; 189(suppl. 1): S1-S3. (Pubitemid 38639561)
41. Muscat M, Bang H, Wohlfahrt J, Glismann S, Molbak K. Measles in Europe: an epidemiological assessment. Lancet 2009; 373: 383-9.
42. Parent du Chatelet I, Levy-Bruhl D. Département des Maladies Infectieuses. Surveillance de la rougeole en France: bilan et évolution de la maladie. Rapport INVS. 2004, p. 45.
43. Hutchins SS, Papania MJ, Amler R, et al. Evaluation of the measles clinical case definition. J Infect Dis 2004; 189(suppl. 1): S153-9.
44. Parent du Chatelet I, Floret D, Antona D, Levy-Bruhl D. Measles resurgence in France in 2008, a preliminary report. Euro Surveill 2009; 14: 1-3.
45. Quinet B. Rougeole. In: Pathologie infectieuse de l'enfant. Paris: Masson (éditeurs), 1999.
46. Riddell MA, Rota JS, Rota PA. Review of the temporal and geographical distribution of measles virus genotypes in the prevaccine and postvaccine eras. Virol J 2005; 2: 87.
47. Zhang Y, Ding Z, Wang H, et al. New measles virus genotype associated with outbreak, China. Emerg Infect Dis 2010; 16: 943-7.
48. Nomenclature for describing the genetic characteristics of wild-type measles viruses (update). Part I. Wkly Epidemiol Rec 2001; 76: 242-7.
49. Mbugua FM, Okoth FA, Gray M, et al. Molecular epidemiology of measles virus in Kenya. J Med Virol 2003; 71: 599-604. (Pubitemid 37309933)
50. Waku-Kouomou D, Freymuth F, du Chatelet IP, Wild TF, Horvat B. Co-circulation of multiple measles virus genotypes during an epidemic in France in 2008. J Med Virol 2010; 82: 1033-43.
51. Editorial Team. Measles once again endemic in the United Kingdom. Euro Surveill 2008; 13: 18919.
52. Lambert SB, Kelly HA, Andrews RM, et al. Enhanced measles surveillance during an interepidemic period in Victoria. Med J Aust 2000; 172: 114-8. (Pubitemid 30111110)
53. Forthal DN, Aarnaes S, Blanding J, de la Maza L, Tilles JG. Degree and length of viremia in adults with measles. J Infect Dis 1992; 166: 421-4.
54. Fulton RE, Middleton PJ. Immunofluorescence in diagnosis of measles infections in children. J Pediatr 1975; 86: 17-22.
55. Kobune F, Sakata H, Sugiura A. Marmoset lymphoblastoid cells as a sensitive host for isolation of measles virus. J Virol 1990; 64: 700-5. (Pubitemid 20032685)
56. Ono N, Tatsuo H, Hidaka Y, Aoki T, Minagawa H, Yanagi Y. Measles viruses on throat swabs from measles patients use signaling lymphocytic activation molecule (CDw150) but not CD46 as a cellular receptor. J Virol 2001; 75: 4399-401. (Pubitemid 32410152)
57. Esolen LM, Park SW, Hardwick JM, Griffin DE. Apoptosis as a cause of death in measles virus-infected cells. J Virol 1995; 69: 3955-8.
58. McKimm-Breschkin JL, Breschkin AM, Rapp F. Characterization of the Halle SSPE measles virus isolate. J Gen Virol 1982; 59: 57-64. (Pubitemid 12155885)
59. Kleiman MB, Blackburn CK, Zimmerman SE, French ML. Comparison of enzyme-linked immunosorbent assay for acute measles with hemagglutination inhibition complement fixation, and fluorescent-antibody methods. J Clin Microbiol 1981; 14: 147-52. (Pubitemid 11095513)
60. Tuokko H, Salmi A. Detection of IgM antibodies to measles virus by enzyme-immunoassay. Med Microbiol Immunol 1983; 171: 187-98. (Pubitemid 13118560)
61. Ratnam S, Tipples G, Head C, Fauvel M, Fearon M, Ward BJ. Performance of indirect immunoglobulin M (IgM) serology tests and IgM capture assays for laboratory diagnosis of measles. J Clin Microbiol 2000; 38: 99-104. (Pubitemid 30043272)
62. Tuokko H. Detection of acute measles infections by indirect and mucapture enzyme immunoassays for immunoglobulin M antibodies and measles immunoglobulin G antibody avidity enzyme immunoassay. J Med Virol 1995; 45: 306-11.
63. Lee MS, Nokes DJ, Hsu HM, Lu CF. Protective titres of measles neutralising antibody. J Med Virol 2000; 62: 511-7.
64. de Swart RL, Yuksel S, Osterhaus AD. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J Virol 2005; 79: 11547-51. (Pubitemid 41170700)
65. Albrecht P, Herrmann K, Burns GR. Role of virus strain in conventional and enhanced measles plaque neutralization test. J Virol Methods 1981; 3: 251-60. (Pubitemid 12194448)
66. Chen RT, Markowitz LE, Albrecht P, et al. Measles antibody: reevaluation of protective titers. J Infect Dis 1990; 162: 1036-42. (Pubitemid 20353580)
67. Neumann PW, Weber JM, Jessamine AG, O'Shaughnessy MV. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J Clin Microbiol 1985; 22: 296-8. (Pubitemid 15006974)
68. van den Hof S, van Gageldonk-Lafeber AB, van Binnendijk RS, van Gageldonk PG, Berbers GA. Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay. Vaccine 2003; 21: 4210-4. (Pubitemid 37130266)
69. Rabenau HF, Marianov B, Wicker S, Allwinn R. Comparison of the neutralizing and ELISA antibody titres to measles virus in human sera and in gamma globulin preparations. Med Microbiol Immunol 2007; 196: 151-5. (Pubitemid 47300251)
70. Rota PA, Featherstone DA, Bellini WJ. Molecular epidemiology of measles virus. Curr Top Microbiol Immunol 2009; 330: 129-50.
71. Godec MS, Asher DM, Swoveland PT, et al. Detection of measles virus genomic sequences in SSPE brain tissue by the polymerase chain reaction. J Med Virol 1990; 30: 237-44. (Pubitemid 20203824)
72. Shimizu H, McCarthy CA, Smaron MF, Burns JC. Polymerase chain reaction for detection of measles virus in clinical samples. J Clin Microbiol 1993; 31: 1034-9. (Pubitemid 23129417)
73. Jin L, Richards A, Brown DW. Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol Cell Probes 1996; 10: 191-200. (Pubitemid 26179290)
74. Mosquera Mdel M, de Ory F, Moreno M, Echevarria JE. Simultaneous detection of measles virus, rubella virus, and parvovirus B19 by using multiplex PCR. J Clin Microbiol 2002; 40: 111-6. (Pubitemid 34027610)
75. Hubschen JM, Kremer JR, De Landtsheer S, Muller CP. A multiplex TaqMan PCR assay for the detection of measles and rubella virus. J Virol Methods 2008; 149: 246-50.
76. Riddell MA, Chibo D, Kelly HA, Catton MG, Birch CJ. Investigation of optimal specimen type and sampling time for detection of measles virus RNA during a measles epidemic. J Clin Microbiol 2001; 39: 375-6. (Pubitemid 32059625)
77. Nokes DJ, Nigatu W, Abebe A, et al. A comparison of oral fluid and serum for the detection of rubella-specific antibodies in a community study in Addis Ababa, Ethiopia. Trop Med Int Health 1998; 3: 258-67. (Pubitemid 28232662)
78. Brown DW, Ramsay ME, Richards AF, Miller E. Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3. BMJ 1994; 308: 1015-7.
79. Anon, & World Health Organization. Recommendations from an ad hoc meeting of the WHO measles and rubella meeting of WHO measles and rubella network (LabNet) on use of alternative diagnostic samples for measles and rubella surveillance. MMWR 2008; 57. 657-660.
80. Parry JV, Perry KR, Mortimer PP. Sensitive assays for viral antibodies in saliva: an alternative to tests on serum. Lancet 1987; 2: 72-5. (Pubitemid 17090511)
81. Nigatu W, Nokes DJ, Enquselassie F, et al. Detection of measles specific IgG in oral fluid using an FITC/anti-FITC IgG capture enzyme linked immunosorbent assay (GACELISA). J Virol Methods 1999; 83: 135-44. (Pubitemid 29528552)
82. Nokes DJ, Enquselassie F, Nigatu W, et al. Has oral fluid the potential to replace serum for the evaluation of population immunity levels? A study of measles, rubella and hepatitis B in rural Ethiopia. Bull World Health Organ 2001; 79: 588-95. (Pubitemid 32678444)
83. Granade TC, Phillips SK, Parekh B, et al. Detection of antibodies to human immunodeficiency virus type 1 in oral fluids: a large-scale evaluation of immunoassay performance. Clin Diagn Lab Immunol 1998; 5: 171-5. (Pubitemid 28161184)
84. Samuel D, Sasnauskas K, Jin L, et al. Development of a measles specific IgM ELISA for use with serum and oral fluid samples using recombinant measles nucleoprotein produced in Saccharomyces cerevisiae. J Clin Virol 2003; 28: 121-9. (Pubitemid 37040864)
85. Kremer JR, Brown KE, Jin L, et al. High genetic diversity of measles virus, World Health Organization European Region, 2005-2006. Emerg Infect Dis 2008; 14: 107-14.